Computationally guided high-throughput design of self-assembling drug nanoparticles
Daniel Reker,Yulia Rybakova,Ameya R Kirtane,Ruonan Cao,Jee Won Yang,Natsuda Navamajiti,Apolonia Gardner,Rosanna M Zhang,Tina Esfandiary,Johanna L'Heureux,Thomas von Erlach,Elena M Smekalova,Dominique Leboeuf,Kaitlyn Hess,Aaron Lopes,Jaimie Rogner,Joy Collins,Siddartha M Tamang,Keiko Ishida,Paul Chamberlain,DongSoo Yun,Abigail Lytton-Jean,Christian K Soule,Jaime H Cheah,Alison M Hayward,Robert Langer,Giovanni Traverso
DOI: https://doi.org/10.1038/s41565-021-00870-y
Abstract:Nanoformulations of therapeutic drugs are transforming our ability to effectively deliver and treat a myriad of conditions. Often, however, they are complex to produce and exhibit low drug loading, except for nanoparticles formed via co-assembly of drugs and small molecular dyes, which display drug-loading capacities of up to 95%. There is currently no understanding of which of the millions of small-molecule combinations can result in the formation of these nanoparticles. Here we report the integration of machine learning with high-throughput experimentation to enable the rapid and large-scale identification of such nanoformulations. We identified 100 self-assembling drug nanoparticles from 2.1 million pairings, each including one of 788 candidate drugs and one of 2,686 approved excipients. We further characterized two nanoparticles, sorafenib-glycyrrhizin and terbinafine-taurocholic acid both ex vivo and in vivo. We anticipate that our platform can accelerate the development of safer and more efficacious nanoformulations with high drug-loading capacities for a wide range of therapeutics.